Ropella

 

Overview

Current

 
• Chairman of the Board and General Counsel at Nanotherapeutics, Inc.
 
• Adjunct Professor at University of Virginia School of Law
 
• Director, Chair of Executive and Audit Committee at Unified Financial Services

 

Past

 
• Managing Director at Americas Biotech Distributor
 
• Chairman and President at Ixion Biotechnology
 
• Senior Advisor at Bush Quayle Relection Campaign Staff

 

Education

 
• University of Virginia School of Law
 
• Dartmouth College
 
• Heidelberg American High School

 

Summary

Domestic and international experience in biotechnology. Track record of success in entrepreneurial and large company environments, building new businesses, developing biotechnology drugs and devices and managing regulatory affairs for biotechnology products, strategic and operational business plan development, raising seed and institutional investment capital, and developing strategic corporate relationships. Also, Chairman of Audit Committee (Unified Financial Services) and member of Audit Committee (Nanotherapeutics, Inc.).

 

Specialties

 
• Audit Committee financial expert.

 

 

Experience

Chairman of the Board and General Counsel, Nanotherapeutics, Inc.

Nanotechnology industry
January 2008 – Present (3 years 2 months)
Non-executive chairman and house counsel of an emerging specialty pharmaceutical company.

 

Adjunct Professor, University of Virginia School of Law

Pharmaceuticals industry
2005 – Present (6 years)

 

Director, Chair of Executive and Audit Committee, Unified Financial Services

Privately Held; 51-200 employees; Financial Services industry
January 1995 – Present (16 years 2 months)
Provider of mid market 401(k) plan services to plan sponsors and wealth management for individuals. Open architecture (no proprietary products), certified by the Center for Fiduciary Excellence (CEFEX).

 

Managing Director, Americas Biotech Distributor

Biotechnology industry
May 2004 – September 2009 (5 years 5 months)
Distributor of US pharmaceutical and biologic products and devices in Latin America

 

Chairman and President, Ixion Biotechnology

Privately Held; 11-50 employees; Biotechnology industry
June 1995 – June 2007 (12 years 1 month)
Start up and clinical stage biotechnology company with probiotic treatment for primary hyperoxaluria (since acquired by OxThera, Inc.) and stem cell treatment for type 1 diabetes. Company has ceased active operations.

 

Senior Advisor, Bush Quayle Relection Campaign Staff

Non-Profit; 201-500 employees; Political Organization industry
March 1992 – November 1992 (9 months)
National campaign staff for re-election of George H.W. Bush, Senior Advisor, Financial Industry.

 

Executive Vice President and General Counsel, Mutual of New York

Pharmaceuticals industry
1985 – 1992 (7 years)

 

Executive VP and General Counsel, Mutual Life Insurance Company of NY (MONY)

Public Company; 5001-10,000 employees; Insurance industry
May 1985 – February 1992 (6 years 10 months)
Mutual life insurance company with other financial services.

 

Vice President - Strategic Projects, Indian Head, Inc.

Pharmaceuticals industry
1979 – 1985 (6 years)

 

Associate, Dewey Ballantine LLP

Partnership; 1001-5000 employees; Law Practice industry
December 1970 – January 1979 (8 years 2 months)
Law partnership, now named Dewey & LeBoeuf, previously called Dewey, Ballantine, Bushby, Palmer & Wood.

 

Education

University of Virginia School of Law

JD

1965 – 1968
Activities and Societies: Order of the Coif

 

Dartmouth College

AB, Philosophy

1961 – 1965
Activities and Societies: Mountain & Winter Warfare, ROTC, Dartmouth Forensic Union (debate) - National Debate team, Sigma Phi Epsilon

 

Heidelberg American High School